JP7817925B2 - 寿命を延長するための組成物及び方法 - Google Patents

寿命を延長するための組成物及び方法

Info

Publication number
JP7817925B2
JP7817925B2 JP2022520294A JP2022520294A JP7817925B2 JP 7817925 B2 JP7817925 B2 JP 7817925B2 JP 2022520294 A JP2022520294 A JP 2022520294A JP 2022520294 A JP2022520294 A JP 2022520294A JP 7817925 B2 JP7817925 B2 JP 7817925B2
Authority
JP
Japan
Prior art keywords
elegans
animals
composition
bacterial strain
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022520294A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021067100A5 (https=
JP2022551584A5 (https=
JP2022551584A (ja
Inventor
アマラナート ゴビンダン，ジョティ
ジャヤマニ，エランパリティ
エイチ チャター，プリーティ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Marvelbiome Inc
Original Assignee
Marvelbiome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marvelbiome Inc filed Critical Marvelbiome Inc
Publication of JP2022551584A publication Critical patent/JP2022551584A/ja
Publication of JPWO2021067100A5 publication Critical patent/JPWO2021067100A5/ja
Publication of JP2022551584A5 publication Critical patent/JP2022551584A5/ja
Priority to JP2025184329A priority Critical patent/JP2026021466A/ja
Application granted granted Critical
Publication of JP7817925B2 publication Critical patent/JP7817925B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/302—Foods, ingredients or supplements having a functional effect on health having a modulating effect on age
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/20—Natural extracts
    • A23V2250/208—Fungi extracts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/02—Acetobacter
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2022520294A 2019-10-01 2020-09-23 寿命を延長するための組成物及び方法 Active JP7817925B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025184329A JP2026021466A (ja) 2019-10-01 2025-10-31 寿命を延長するための組成物及び方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962909186P 2019-10-01 2019-10-01
US62/909,186 2019-10-01
PCT/US2020/052251 WO2021067100A1 (en) 2019-10-01 2020-09-23 Compositions and methods for extending lifespan

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025184329A Division JP2026021466A (ja) 2019-10-01 2025-10-31 寿命を延長するための組成物及び方法

Publications (4)

Publication Number Publication Date
JP2022551584A JP2022551584A (ja) 2022-12-12
JPWO2021067100A5 JPWO2021067100A5 (https=) 2023-09-28
JP2022551584A5 JP2022551584A5 (https=) 2023-09-28
JP7817925B2 true JP7817925B2 (ja) 2026-02-19

Family

ID=75337328

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022520294A Active JP7817925B2 (ja) 2019-10-01 2020-09-23 寿命を延長するための組成物及び方法
JP2025184329A Withdrawn JP2026021466A (ja) 2019-10-01 2025-10-31 寿命を延長するための組成物及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025184329A Withdrawn JP2026021466A (ja) 2019-10-01 2025-10-31 寿命を延長するための組成物及び方法

Country Status (9)

Country Link
US (1) US20220330597A1 (https=)
EP (1) EP4037697A4 (https=)
JP (2) JP7817925B2 (https=)
KR (1) KR20220073796A (https=)
CN (1) CN114555102A (https=)
AU (1) AU2020359357A1 (https=)
CA (1) CA3153779A1 (https=)
IL (2) IL291798B2 (https=)
WO (1) WO2021067100A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114365845B (zh) * 2022-02-18 2023-03-28 吉林大学 一种植物发酵组合物及其制备方法和应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019147652A1 (en) 2018-01-23 2019-08-01 The General Hospital Corporation Compositions and methods for improving mitochondrial function

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003000861A2 (en) * 2001-06-22 2003-01-03 The Regents Of The University Of California Eukaryotic genes involved in adult lifespan regulation
JP2008214215A (ja) * 2007-03-01 2008-09-18 Mitsukan Group Honsha:Kk アポトーシス誘導能を有する組成物
WO2014102588A2 (en) * 2012-12-27 2014-07-03 Purdue Pharma L.P. Indole and indoline-type piperidine compounds and uses thereof
US20160051596A1 (en) * 2014-08-21 2016-02-25 Food Industry Research And Development Institute Novel acetobacter and gluconacetobacter strains and their metabolites for use in inhibiting xanthine oxidase
US9867857B2 (en) * 2014-08-21 2018-01-16 Food Industry Research And Development Institute Acetobacter and gluconacetobacter strains and their metabolites for use in inhibiting xanthine oxidase
US10722543B2 (en) * 2016-01-28 2020-07-28 Oxyrase, Inc. Methods for inhibiting tumor growth using anaerobe microorganisms
JP2018131416A (ja) * 2017-02-16 2018-08-23 国立大学法人 鹿児島大学 免疫増強剤及びその製造方法
US11497235B2 (en) * 2017-09-04 2022-11-15 Kewpie Corporation Acetic bacterial cell-containing food composition and method of producing the same
EP4028558A4 (en) * 2019-09-12 2024-01-03 MarvelBiome, Inc. Compositions and methods for characterizing a microbiome
KR20240113455A (ko) * 2021-09-17 2024-07-22 마블바이옴 인코포레이티드 신경퇴행성 질환을 치료하기 위한 마이크로바이옴 조성물, 성분 또는 대사산물의 방법 및 용도

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019147652A1 (en) 2018-01-23 2019-08-01 The General Hospital Corporation Compositions and methods for improving mitochondrial function
US20190255124A1 (en) 2018-01-23 2019-08-22 The General Hospital Corporation Compositions and methods for improving mitochondrial function

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Food Control，2011年，22，p.647-656

Also Published As

Publication number Publication date
EP4037697A1 (en) 2022-08-10
CA3153779A1 (en) 2021-04-08
IL291798B2 (en) 2025-10-01
AU2020359357A1 (en) 2022-04-28
KR20220073796A (ko) 2022-06-03
CN114555102A (zh) 2022-05-27
IL320580A (en) 2025-07-01
JP2026021466A (ja) 2026-02-10
IL291798A (en) 2022-06-01
EP4037697A4 (en) 2024-04-03
WO2021067100A1 (en) 2021-04-08
IL291798B1 (en) 2025-06-01
JP2022551584A (ja) 2022-12-12
US20220330597A1 (en) 2022-10-20

Similar Documents

Publication Publication Date Title
JP7676369B2 (ja) 組成物、及びマイクロバイオームを特性評価するための方法
Romaní‐Pérez et al. Holdemanella biformis improves glucose tolerance and regulates GLP‐1 signaling in obese mice
Glenny et al. Eating disorders and the intestinal microbiota: mechanisms of energy homeostasis and behavioral influence
Grompone et al. Anti-inflammatory Lactobacillus rhamnosus CNCM I-3690 strain protects against oxidative stress and increases lifespan in Caenorhabditis elegans
US11957723B2 (en) Methods and uses of microbiome compositions, components, or metabolites for treating neurodegenerative diseases
McKean et al. The costs of immunity and the evolution of immunological defense mechanisms
JP2026021466A (ja) 寿命を延長するための組成物及び方法
Heimesaat et al. Intestinal microbiota changes in mice lacking pituitary adenylate cyclase activating polypeptide (PACAP)—bifidobacteria make the difference
RU2854523C1 (ru) Композиции и способы для увеличения продолжительности жизни
CN116847859A (zh) 微生物组组合物的方法和用途
HK40076210A (en) Compositions and methods for extending lifespan
Mir et al. Roles of progranulin and FRamides in neural versus non-neural tissues on dietary restriction-related longevity and proteostasis in C. elegans
Pei et al. Impaired colonic motility in high-glycemic diet-induced diabetic mice is associated with disrupted gut microbiota and neuromuscular function
CN121926964A (zh) 用于延长寿命的组合物和方法
HK40076257A (en) Compositions and methods for characterizing a microbiome
Nouar Using Caenorhabditis elegans as a model to investigate host-microbiome interactions in Parkinson’s disease
Delprete Pathogenetic mechanisms of gastrointestinal symptoms in a mouse model of Fabry disease: insights on the microbiota-gut-brain axis
Arentsen Gut Microbes and the Developing Brain.
Kudzminskaite A model system to investigate microbiome effects on age-related health in C. elegans
Joldrichsen Paneth Cells Regulate Innate Immune Cell Populations, and Contribute to Allergy and Obesity Disease Progression
Gallo Microbiota in host health and disease: dissecting the influence of gut microbes on Drosophila growth and Zebrafish intestinal inflammation
CN117320692A (zh) 微生物组组合物、组分或代谢物用于治疗眼睛病症的方法和用途
Hanuschak Investigating the microbial and immune mechanisms of depressive-like behaviour in a humanized mouse model of MDD
Sovran Mucus and gut barrier in health and disease
QUATTRONE et al. TYPE 1 DIABETES AND THE GUT

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230915

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230915

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241126

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250225

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250425

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250526

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250701

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251031

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20251031

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260113

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260206

R150 Certificate of patent or registration of utility model

Ref document number: 7817925

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150